Abstract
In the sixth in a series of six articles on packages of care for mental disorders in low- and middle-income countries, Alan Flisher and colleagues discuss the treatment of attention-deficit hyperactivity disorder.
MeSH terms
-
Attention Deficit Disorder with Hyperactivity / diagnosis*
-
Attention Deficit Disorder with Hyperactivity / drug therapy
-
Attention Deficit Disorder with Hyperactivity / therapy*
-
Developing Countries
-
Dopamine Uptake Inhibitors / therapeutic use
-
Health Services Accessibility
-
Humans
-
Methylphenidate / therapeutic use
-
Primary Health Care / methods
Substances
-
Dopamine Uptake Inhibitors
-
Methylphenidate